Editas Medicine (EDIT) Accumulated Depreciation & Amortization: 2015-2025
Historic Accumulated Depreciation & Amortization for Editas Medicine (EDIT) over the last 10 years, with Sep 2025 value amounting to $27.5 million.
- Editas Medicine's Accumulated Depreciation & Amortization fell 9.77% to $27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $113.7 million, marking a year-over-year increase of 0.32%. This contributed to the annual value of $31.6 million for FY2024, which is 20.52% up from last year.
- According to the latest figures from Q3 2025, Editas Medicine's Accumulated Depreciation & Amortization is $27.5 million, which was up 2.68% from $26.8 million recorded in Q2 2025.
- Editas Medicine's 5-year Accumulated Depreciation & Amortization high stood at $31.6 million for Q4 2024, and its period low was $12.0 million during Q1 2021.
- Over the past 3 years, Editas Medicine's median Accumulated Depreciation & Amortization value was $27.5 million (recorded in 2025), while the average stood at $27.0 million.
- Per our database at Business Quant, Editas Medicine's Accumulated Depreciation & Amortization skyrocketed by 49.79% in 2021 and then declined by 9.77% in 2025.
- Over the past 5 years, Editas Medicine's Accumulated Depreciation & Amortization (Quarterly) stood at $15.5 million in 2021, then surged by 38.81% to $21.5 million in 2022, then rose by 21.99% to $26.3 million in 2023, then increased by 20.52% to $31.6 million in 2024, then decreased by 9.77% to $27.5 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $27.5 million for Q3 2025, versus $26.8 million for Q2 2025 and $27.7 million for Q1 2025.